معرفی
Dr. Erin Godecke is an Associate Professor and Senior Research Fellow in Speech Pathology at Edith Cowan University (ECU), specializing in aphasia recovery and stroke rehabilitation. She leads the Very Early Rehabilitation in Speech (VERSE) trial, Australia’s largest aphasia rehabilitation trial, and serves as Clinical Director. Her work focuses on very early post-stroke aphasia intervention, stroke care quality improvement, and impairment-based therapy. She has held leadership roles in national stroke initiatives and is a member of the European Union’s Aphasia Trialists (CATs) committee.
Education:
- Doctor of Philosophy (Speech Pathology), Curtin University, 2009 (part-time)
- Master of Science (Speech and Hearing Science), Curtin University, 1999
- Bachelor of Science (Speech & Hearing Science), Curtin University, 1996
Research Interests: Dr. Godecke’s research emphasizes early aphasia intervention efficacy, stroke care quality metrics, and culturally secure rehabilitation for Aboriginal Australians. Her work includes economic evaluations of aphasia therapies and global consensus-building for stroke rehabilitation standards.
Key Projects:
- VERSE trial: Investigates early aphasia therapy efficacy and cost-effectiveness
- COMPARE trial: Evaluates constraint-induced vs. multimodal aphasia therapy
- Healing Right Way: Enhances culturally appropriate brain injury care for Aboriginal communities
Awards:
- Stroke Society of Australasia Scientific Award
- Rotary Allied Health Professional of the Year (WA)
- Johnson & Johnson Excellence in Clinical Care Scholarship
Grants & Leadership: Leads over $6M in NHMRC grants, including the Centre of Research Excellence in Aphasia Recovery. She chairs national stroke quality initiatives and advises the Australian Commission on Safety and Quality in Health Care.
Labs/Teams: Co-leads the ECU Aphasia Research Group and collaborates with global networks like the Stroke Recovery and Rehabilitation Roundtable.
